Hematopoietic/Lymphoid Cancer Active Not Recruiting Phase 2 Trials for Filgrastim (DB00099)

IndicationStatusPhase
DBCOND0030132 (Hematopoietic/Lymphoid Cancer)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs